Abnormal expression of lysosomal glycoproteins in patients with congenital disorders of glycosylation

BMC Res Notes. 2023 Apr 17;16(1):53. doi: 10.1186/s13104-023-06314-1.

Abstract

The study of the impact of some inherited defects in glycosylation on the biosynthesis of some lysosomal glycoproteins. Results description: Whole-exome sequencing revealed a homozygous variant; 428G > A; p. (R143K) in SRD5A3 in one patient and a heterozygous one c.46G > A p. (Gly16Arg) in SLC35A2 in the other patient. Both variants were predicted to be likely pathogenic. Lysosome-associated membrane glycoprotein 2 (LAMP2) immunodetection in both cases showed a truncated form of the protein. Cystinosin (CTN) protein appeared as normal and truncated forms in both patients in ratios of the mature to truncated forms of CTN were lower than the control. The levels of the truncated forms of both cellular proteins were higher in the SRD5A3-CDG case compared to the SLC35A2-CDG case. The tetrameric form of cathepsin C (CTSC) was expressed at low levels in both cases with congenital disorder of glycosylation (CDG). SLC35A2-CDG patient had one extra-unknown band while SRD5A3-CDG patient had a missing band of CTSC forms. The expression patterns of lysosomal glycoproteins could be different between different types of CDG.

Keywords: Cathepsin C; Congenital disorders of glycosylation; Cystinosin; Lysosome-associated membrane; Lysosomes; Total leukocytes.

MeSH terms

  • Congenital Disorders of Glycosylation* / diagnosis
  • Congenital Disorders of Glycosylation* / genetics
  • Congenital Disorders of Glycosylation* / metabolism
  • Glycoproteins / genetics
  • Glycoproteins / metabolism
  • Glycosylation
  • Homozygote
  • Humans
  • Lysosomes / metabolism
  • Lysosomes / pathology
  • Mutation

Substances

  • Glycoproteins